StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Scynexis's total debt was $0 at Sep 30, 2022. For fiscal 2021 it was $0. The highest annual figure on record is $15.08M in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$15.08M+2.9%
FY2017Dec 31, 2017$14.65M+2.8%
FY2016Dec 31, 2016$14.25M–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$15.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$0–
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$0-100.0%
Q4 FY2018Dec 31, 2018$15.08M+2.9%
Q3 FY2018Sep 30, 2018$14.97M+2.8%
Q2 FY2018Jun 30, 2018$14.86M+2.9%
Q1 FY2018Mar 31, 2018$14.76M+2.9%
Q4 FY2017Dec 31, 2017$14.65M+2.8%
Q3 FY2017Sep 30, 2017$14.55M+2.7%
Q2 FY2017Jun 30, 2017$14.45M–
Q1 FY2017Mar 31, 2017$14.35M–
Q4 FY2016Dec 31, 2016$14.25M–
Q3 FY2016Sep 30, 2016$14.17M–

More Scynexis figures

See a number that looks wrong?